Risk calculators have traditionally utilized PSA values in addition to the clinical variables to predict risk assessment of prostate cancer (PCa). For the first time, we aimed to develop pre-biopsy mpMRI based simple risk score (RS) and a predictive model in predicting the risk of PCa in men with clinically challenging value of PSA (4-10 ng/ml) if a TRUS-guided biopsy is performed. The predictive model and developed simplistic 6-point mpMRI score based risk calculator in this study could be routinely used in predicting PCa in clinical management for men with PSA 4-10 ng/ml.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords